Hakutulokset - Vaknin‐Dembinsky, Adi

COVID-19 in Cladribine-treated patient with multiple sclerosis Tekijä Haham, Nitsan, Vaknin-Dembinsky, Adi

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Effects of Supermagnetic Iron Oxide Labeling on the Major Functional Properties of Human Mesenchymal Stem Cells from Multiple Sclerosis Patients Tekijä Kassis, Ibrahim, Vaknin-Dembinsky, Adi, Bulte, Jeff, Karussis, Dimitrios

Hae kokoteksti Hae kokoteksti

Neuroinflammation Modulation via α7 Nicotinic Acetylcholine Receptor and Its Chaperone, RIC-3 Tekijä Mizrachi, Tehila, Vaknin-Dembinsky, Adi, Brenner, Talma, Treinin, Millet

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS Tekijä Vaknin-Dembinsky, Adi, Brass, Steven, Gandhi, Roopali, Weiner, Howard L.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis Tekijä Lavon, Iris, Heli, Coral, Brill, Livnat, Charbit, Hanna, Vaknin-Dembinsky, Adi

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis Tekijä Vaknin-Dembinsky, Adi, Murugaiyan, Gopal, Hafler, David A., Astier, Anne L., Weiner, Howard L.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Interferon-beta Inhibits Toll-Like Receptor 9 Processing in Multiple Sclerosis Tekijä Balashov, Konstantin E., Aung, Latt Latt, Vaknin-Dembinsky, Adi, Dhib-Jalbut, Suhayl, Weiner, Howard L.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Description of 3 patients with myasthenia gravis and COVID-19 Tekijä Rein, Netaniel, Haham, Nitzan, Orenbuch-Harroch, Efrat, Romain, Marc, Argov, Zohar, Vaknin-Dembinsky, Adi, Gotkine, Marc

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis Tekijä Brill, Livnat, Rechtman, Ariel, Zveik, Omri, Haham, Nitzan, Levin, Netta, Shifrin, Alla, Rozenberg, Ayal, Vaknin-Dembinsky, Adi

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course Tekijä Rechtman, Ariel, Brill, Livnat, Zveik, Omri, Uliel, Benjamin, Haham, Nitzan, Bick, Atira S., Levin, Netta, Vaknin-Dembinsky, Adi

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in Astrocytes Tekijä Zveik, Omri, Rechtman, Ariel, Haham, Nitzan, Adini, Irit, Canello, Tamar, Lavon, Iris, Brill, Livnat, Vaknin-Dembinsky, Adi

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells Tekijä Zveik, Omri, Fainstein, Nina, Rechtman, Ariel, Haham, Nitzan, Ganz, Tal, Lavon, Iris, Brill, Livnat, Vaknin‐Dembinsky, Adi

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO) Tekijä Vaknin-Dembinsky, Adi, Charbit, Hanna, Brill, Livnat, Abramsky, Oded, Gur-Wahnon, Devorah, Ben-Dov, Iddo Z., Lavon, Iris

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Effectiveness of multi-disciplinary rehabilitation for patients with Neuromyelitis Optica Tekijä Nechemia, Yael, Moreh, Elior, Weingarden, Harold, Bloch, Ayala, Givon, Uri, Vaknin-Dembinsky, Adi, Schwartz, Isabella, Meiner, Zeev, Zeilig, Gabi

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107 Tekijä Mizrachi, Tehila, Marsha, Oshrit, Brusin, Karen, Ben-David, Yael, Thakur, Ganesh A., Vaknin-Dembinsky, Adi, Treinin, Millet, Brenner, Talma

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab Tekijä Brill, Livnat, Raposo, Catarina, Rechtman, Ariel, Zveik, Omri, Levin, Netta, Oiknine‐Djian, Esther, Wolf, Dana G., Vaknin‐Dembinsky, Adi

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccine() Tekijä Brill, Livnat, Rechtman, Ariel, Shifrin, Alla, Rozenberg, Ayal, Afanasiev, Svetlana, Zveik, Omri, Haham, Nitzan, Levin, Neta, Vaknin-Dembinsky, Adi

Hae kokoteksti Hae kokoteksti Hae kokoteksti

NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness Tekijä Mizrachi, Tehila, Brill, Livnat, Rabie, Malcolm, Nevo, Yoram, Fellig, Yakov, Zur, Mayan, Karussis, Dimitrios, Abramsky, Oded, Brenner, Talma, Vaknin-Dembinsky, Adi

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel Tekijä Brill, Livnat, Ganelin-Cohen, Esther, Dabby, Ron, Rabinowicz, Shira, Zohar-Dayan, Efrat, Rein, Netaniel, Aloni, Eyal, Karmon, Yuval, Vaknin-Dembinsky, Adi

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab Tekijä Brill, Livnat, Rechtman, Ariel, Zveik, Omri, Haham, Nitzan, Oiknine-Djian, Esther, Wolf, Dana G., Levin, Netta, Raposo, Catarina, Vaknin-Dembinsky, Adi

Hae kokoteksti Hae kokoteksti Hae kokoteksti